mRNA modulating agents (PTC Therapeutics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamemRNA modulating agents (PTC Therapeutics)
Drug Alias NamePTC-1PTC-2
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationGraft vs Host DiseaseDiabetes Mellitus +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPtc Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPtc Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsInflammationGraft vs Host DiseaseDiabetes Mellitus +[10] 

Other Information

ATC CodeN/A
Related LinksN/A